Works matching AU Tabernero, Josep

Results: 158
    1

    Impact of Treatment With Trifturidine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial.

    Published in:
    Clinical Colorectal Cancer, 2025, v. 24, n. 2, p. 180, doi. 10.1016/j.clcc.2024.12.002
    By:
    • Taieb, Julien;
    • Fakih, Marwan;
    • Tabernero, Josep;
    • Ciardiello, Fortunato;
    • Van Cutsem, Eric;
    • Soler, Gemma;
    • Calleja, Elizabeth;
    • Barboux, Valentine;
    • Roby, Lucas;
    • Amellal, Nadia;
    • Prager, Gerald W.
    Publication type:
    Article
    2
    3
    4

    PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system.

    Published in:
    NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00409-5
    By:
    • Zimmer, Kai;
    • Kocher, Florian;
    • Untergasser, Gerold;
    • Kircher, Brigitte;
    • Amann, Arno;
    • Baca, Yasmine;
    • Xiu, Joanne;
    • Korn, W. Micheal;
    • Berger, Martin D.;
    • Lenz, Heinz-Josef;
    • Puccini, Alberto;
    • Fontana, Elisa;
    • Shields, Anthony F.;
    • Marshall, John L.;
    • Hall, Michael;
    • El-Deiry, Wafik S.;
    • Hsiehchen, David;
    • Macarulla, Teresa;
    • Tabernero, Josep;
    • Pichler, Renate
    Publication type:
    Article
    5

    Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials.

    Published in:
    JNCI Cancer Spectrum, 2022, v. 6, n. 2, p. 1, doi. 10.1093/jncics/pkac014
    By:
    • McCleary, Nadine J;
    • Harmsen, William S;
    • Haakenstad, Ellana;
    • Cleary, James M;
    • Meyerhardt, Jeffrey A;
    • Zalcberg, John;
    • Adams, Richard;
    • Grothey, Axel;
    • Sobrero, Alberto F;
    • Cutsem, Eric Van;
    • Goldberg, Richard M;
    • Peeters, Marc;
    • Tabernero, Josep;
    • Seymour, Matt;
    • Saltz, Leonard B;
    • Giantonio, Bruce J;
    • Arnold, Dirk;
    • Rothenberg, Mace L;
    • Koopman, Miriam;
    • Schmoll, Hans-Joachim
    Publication type:
    Article
    6
    7
    8

    Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

    Published in:
    2018
    By:
    • Alsina, Maria;
    • Rivera, Fernando;
    • Ramos, Francisco Javier;
    • Galán, Maica;
    • López, Rafael;
    • García-Alfonso, Pilar;
    • Alés-Martinez, José Enrique;
    • Queralt, Bernardo;
    • Antón, Antonio;
    • Carrato, Alfredo;
    • Grávalos, Cristina;
    • Méndez-Vidal, Maria José;
    • López, Carlos;
    • de Mena, Inmaculada Ruiz;
    • Tabernero, Josep;
    • Giralt, Jordi;
    • Aranda, Enrique;
    • on behalf of the Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR);
    • Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR)
    Publication type:
    journal article
    9

    A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

    Published in:
    2018
    By:
    • Alsina, Maria;
    • Rivera, Fernando;
    • Ramos, Francisco Javier;
    • Galán, Maica;
    • López, Rafael;
    • García-Alfonso, Pilar;
    • Alés-Martinez, José Enrique;
    • Queralt, Bernardo;
    • Antón, Antonio;
    • Carrato, Alfredo;
    • Grávalos, Cristina;
    • Méndez-Vidal, Maria José;
    • López, Carlos;
    • de Mena, Inmaculada Ruiz;
    • Tabernero, Josep;
    • Giralt, Jordi;
    • Aranda, Enrique;
    • on behalf of the Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR);
    • Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR)
    Publication type:
    journal article
    10

    A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer.

    Published in:
    2017
    By:
    • Wainberg, Zev;
    • Alsina, Maria;
    • Soares, Heloisa;
    • Braña, Irene;
    • Britten, Carolyn;
    • Conte, Gianluca;
    • Ezeh, Patrick;
    • Houk, Brett;
    • Kern, Kenneth;
    • Leong, Stephen;
    • Pathan, Nuzhat;
    • Pierce, Kristen;
    • Siu, Lillian;
    • Vermette, Jennifer;
    • Tabernero, Josep;
    • Wainberg, Zev A;
    • Soares, Heloisa P;
    • Braña, Irene;
    • Britten, Carolyn D;
    • Del Conte, Gianluca
    Publication type:
    journal article
    11
    12
    13
    14
    15
    16

    ?-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer.

    Published in:
    Nature Medicine, 2012, v. 18, n. 6, p. 892, doi. 10.1038/nm.2772
    By:
    • Tenbaum, Stephan P;
    • Ordóñez-Morán, Paloma;
    • Puig, Isabel;
    • Chicote, Irene;
    • Arqués, Oriol;
    • Landolfi, Stefania;
    • Fernández, Yolanda;
    • Herance, José Raúl;
    • Gispert, Juan D;
    • Mendizabal, Leire;
    • Aguilar, Susana;
    • Cajal, Santiago Ramón y;
    • Schwartz, Simó;
    • Vivancos, Ana;
    • Espín, Eloy;
    • Rojas, Santiago;
    • Baselga, José;
    • Tabernero, Josep;
    • Muñoz, Alberto;
    • Palmer, Héctor G
    Publication type:
    Article
    17
    18

    The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.

    Published in:
    Nature Genetics, 2009, v. 41, n. 8, p. 882, doi. 10.1038/ng.403
    By:
    • Pomerantz, Mark M.;
    • Ahmadiyeh, Nasim;
    • Jia, Li;
    • Herman, Paula;
    • Verzi, Michael P.;
    • Doddapaneni, Harshavardhan;
    • Beckwith, Christine A.;
    • Chan, Jennifer A.;
    • Hills, Adam;
    • Davis, Matt;
    • Yao, Keluo;
    • Kehoe, Sarah M.;
    • Lenz, Heinz-Josef;
    • Haiman, Christopher A.;
    • Chunli Yan;
    • Henderson, Brian E.;
    • Frenkel, Baruch;
    • Barretina, Jordi;
    • Bass, Adam;
    • Tabernero, Josep
    Publication type:
    Article
    19
    20
    21

    MODUL—a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 6, p. 1197, doi. 10.1007/s00432-018-2632-6
    By:
    • Schmoll, Hans-Joachim;
    • Arnold, Dirk;
    • de Gramont, Aimery;
    • Ducreux, Michel;
    • Grothey, Axel;
    • O’Dwyer, Peter J.;
    • Van Cutsem, Eric;
    • Hermann, Frank;
    • Bosanac, Ivan;
    • Bendahmane, Belguendouz;
    • Mancao, Christoph;
    • Tabernero, Josep
    Publication type:
    Article
    22

    Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.

    Published in:
    Carcinogenesis, 2016, v. 37, n. 9, p. 852, doi. 10.1093/carcin/bgw073
    By:
    • Sclafani, Francesco;
    • Chau, Ian;
    • Cunningham, David;
    • Lampis, Andrea;
    • Hahne, Jens Claus;
    • Ghidini, Michele;
    • Lote, Hazel;
    • Zito, Domenico;
    • Tabernero, Josep;
    • Glimelius, Bengt;
    • Cervantes, Andres;
    • Begum, Ruwaida;
    • De Castro, David Gonzalez;
    • Wilson, Sanna Hulkki;
    • Peckitt, Clare;
    • Eltahir, Zakaria;
    • Wotherspoon, Andrew;
    • Tait, Diana;
    • Brown, Gina;
    • Oates, Jacqueline
    Publication type:
    Article
    23

    Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies.

    Published in:
    PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0129876
    By:
    • Vicario, Rocio;
    • Peg, Vicente;
    • Morancho, Beatriz;
    • Zacarias-Fluck, Mariano;
    • Zhang, Junjie;
    • Martínez-Barriocanal, Águeda;
    • Navarro Jiménez, Alexandra;
    • Aura, Claudia;
    • Burgues, Octavio;
    • Lluch, Ana;
    • Cortés, Javier;
    • Nuciforo, Paolo;
    • Rubio, Isabel T.;
    • Marangoni, Elisabetta;
    • Deeds, James;
    • Boehm, Markus;
    • Schlegel, Robert;
    • Tabernero, Josep;
    • Mosher, Rebecca;
    • Arribas, Joaquín
    Publication type:
    Article
    24
    25
    26
    27
    28

    Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.

    Published in:
    2017
    By:
    • Taieb, Julien;
    • Le Malicot, Karine;
    • Shi, Qian;
    • Penault-Llorca, Frédérique;
    • Bouché, Olivier;
    • Tabernero, Josep;
    • Mini, Enrico;
    • Goldberg, Richard M.;
    • Folprecht, Gunnar;
    • Van Laethem, Jean Luc;
    • Sargent, Daniel J.;
    • Alberts, Steven R.;
    • Emile, Jean Francois;
    • Puig, Pierre Laurent;
    • Sinicrope, Frank A.;
    • Penault Lorca, Frédérique;
    • Bouché, Olivier;
    • Luc Van Laethem, Jean;
    • Francois Emile, Jean;
    • Laurent Puig, Pierre
    Publication type:
    journal article
    29

    A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer.

    Published in:
    2015
    By:
    • Sclafani, Francesco;
    • Kim, Tae Y.;
    • Cunningham, David;
    • Kim, Tae W.;
    • Tabernero, Josep;
    • Schmoll, Hans J.;
    • Roh, Jae K.;
    • Kim, Sun Y.;
    • Park, Young S.;
    • Guren, Tormod K.;
    • Hawkes, Eliza;
    • Clarke, Steven J.;
    • Ferry, David;
    • Frödin, Jan-Erik;
    • Ayers, Mark;
    • Nebozhyn, Michael;
    • Peckitt, Clare;
    • Loboda, Andrey;
    • Mauro, David J.;
    • Watkins, David J.
    Publication type:
    journal article
    30

    nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 2, p. 1, doi. 10.1093/jnci/dju413
    By:
    • Goldstein, David;
    • El-Maraghi, Robert Hassan;
    • Hammel, Pascal;
    • Heinemann, Volker;
    • Kunzmann, Volker;
    • Sastre, Javier;
    • Scheithauer, Werner;
    • Siena, Salvatore;
    • Tabernero, Josep;
    • Teixeira, Luis;
    • Tortora, Giampaolo;
    • Van Laethem, Jean-Luc;
    • Young, Rosemary;
    • Penenberg, Darryl Neil;
    • Lu, Brian;
    • Romano, Alfredo;
    • Von Hoff, Daniel D.
    Publication type:
    Article
    31
    32
    33
    34
    35

    Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 1, p. 1, doi. 10.1093/jnci/djt322
    By:
    • Moutinho, Catia;
    • Martinez-Cardús, Anna;
    • Santos, Cristina;
    • Navarro-Pérez, Valentin;
    • Martinez-Balibrea, Eva;
    • Musulen, Eva;
    • Carmona, F. Javier;
    • Sartore-Bianchi, Andrea;
    • Cassingena, Andrea;
    • Siena, Salvatore;
    • Elez, Elena;
    • Tabernero, Josep;
    • Salazar, Ramon;
    • Abad, Albert;
    • Esteller, Manel
    Publication type:
    Article
    36
    37

    Intrinsic cancer subtypes-next steps into personalized medicine.

    Published in:
    Cellular Oncology (2211-3428), 2015, v. 38, n. 1, p. 3, doi. 10.1007/s13402-014-0203-7
    By:
    • Moreno, Victor;
    • Santos, Cristina;
    • Grasselli, Julieta;
    • Pernas, Sonia;
    • Salazar, Ramon;
    • Sanz-Pamplona, Rebeca;
    • Nadal, Ernest;
    • Dienstmann, Rodrigo;
    • Tabernero, Josep
    Publication type:
    Article
    38

    A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors.

    Published in:
    Science Translational Medicine, 2023, v. 15, n. 695, p. 1, doi. 10.1126/scitranslmed.abp9229
    By:
    • Melero, Ignacio;
    • Tanos, Tamara;
    • Bustamante, Mariana;
    • Sanmamed, Miguel F.;
    • Calvo, Emiliano;
    • Moreno, Irene;
    • Moreno, Victor;
    • Hernandez, Tatiana;
    • Martinez Garcia, Maria;
    • Rodriguez-Vida, Alejo;
    • Tabernero, Josep;
    • Azaro, Analia;
    • Ponz-Sarvisé, Mariano;
    • Spanggaard, Iben;
    • Rohrberg, Kristoffer;
    • Guarin, Ernesto;
    • Nüesch, Eveline;
    • Davydov, Iakov I.;
    • Ooi, Chiahuey;
    • Duarte, José
    Publication type:
    Article
    39
    40
    41

    Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.

    Published in:
    2010
    By:
    • Di Nicolantonio, Federica;
    • Arena, Sabrina;
    • Tabernero, Josep;
    • Grosso, Stefano;
    • Molinari, Francesca;
    • Macarulla, Teresa;
    • Russo, Mariangela;
    • Cancelliere, Carlotta;
    • Zecchin, Davide;
    • Mazzucchelli, Luca;
    • Sasazuki, Takehiko;
    • Shirasawa, Senji;
    • Geuna, Massimo;
    • Frattini, Milo;
    • Baselga, José;
    • Gallicchio, Margherita;
    • Biffo, Stefano;
    • Bardelli, Alberto;
    • Baselga, José
    Publication type:
    journal article
    42
    43
    44
    45
    46
    47
    48

    Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 1, p. 75, doi. 10.1007/s00280-010-1285-1
    By:
    • Rivera, Fernando;
    • Galán, Maica;
    • Tabernero, Josep;
    • Cervantes, Andres;
    • Vega-Villegas, Mª;
    • Gallego, Javier;
    • Laquente, Berta;
    • Rodríguez, Edith;
    • Carrato, Alfredo;
    • Escudero, Pilar;
    • Massutí, Bartomeu;
    • Alonso-Orduña, Vicente;
    • Cardenal, Adelaida;
    • Sáenz, Alberto;
    • Giralt, Jordi;
    • Yuste, Ana;
    • Antón, Antonio;
    • Aranda, Enrique
    Publication type:
    Article
    49

    Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 6, p. 1075, doi. 10.1007/s00280-008-0700-3
    By:
    • Font, Albert;
    • Salazar, Ramon;
    • Maurel, Joan;
    • Taron, Miquel;
    • Ramirez, Jose Luis;
    • Tabernero, Josep;
    • Gallego, Rosa;
    • Casado, Esther;
    • Manzano, Jose Luis;
    • Carcereny, Enric;
    • Guix, Marta;
    • Fernández-Llamazares, Jaume;
    • Rosell, Rafael
    Publication type:
    Article
    50